IceCure Medical Ltd.(ICCM),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ICCM IceCure Medical Ltd.

Trading 05-04 15:34:56 EDT

0.2950

-0.0063

-2.09%

High0.3200	Low0.2950	Vol222.21K
Open0.3027	D1 Closing0.3013	Amplitude8.30%
Mkt Cap23.95M	Tradable Cap15.73M	Total Shares81.18M
T/O68.19K	T/O Rate0.42%	Tradable Shares53.31M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ICCM","market":"US","secType":"STK","nameCN":"IceCure Medical Ltd.","latestPrice":0.295,"timestamp":1777923261063,"preClose":0.3013,"halted":0,"volume":222206,"delay":0,"changeRate":-0.0209093926319284,"floatShares":53305400,"shares":81180000,"eps":-0.236822,"marketStatus":"Trading","change":-0.0063,"latestTime":"05-04 15:34:56 EDT","open":0.3027,"high":0.32,"low":0.295,"amount":68188.75519079999,"amplitude":0.082974,"askPrice":0.3023,"askSize":100,"bidPrice":0.2934,"bidSize":1200,"shortable":3,"etf":0,"ttmEps":-0.236822,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1777924800000},"marketStatusCode":2,"adr":0,"listingDate":1629950400000,"exchange":"NASDAQ","adjPreClose":0.3013,"preHourTrading":{"tag":"盘前","latestPrice":0.31,"preClose":0.3013,"latestTime":"08:07 EDT","volume":2004,"amount":622.6874892,"timestamp":1777896470986,"change":0.0087,"changeRate":0.028875,"amplitude":0.077995},"postHourTrading":{"tag":"盘后","latestPrice":0.3125,"preClose":0.3013,"latestTime":"18:50 EDT","volume":4981,"amount":1509.0431,"timestamp":1777675828167,"change":0.0112,"changeRate":0.037172,"amplitude":0.071026},"volumeRatio":0.434167},"requestUrl":"/m/hq/s/ICCM/tweets","defaultTab":"tweets","newsList":[{"id":"2632937965","title":"Icecure Medical Ltd : Alliance Global Partners Initiates Coverage With Buy Rating; Target Price $1","url":"https://stock-news.laohu8.com/highlight/detail?id=2632937965","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632937965?lang=en_us&edition=fundamental","pubTime":"2026-05-04 19:02","pubTimestamp":1777892559,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nFWN41H0KZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","ICCM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629075614","title":"IceCure Medical announces special shareholder meeting via remote communication","url":"https://stock-news.laohu8.com/highlight/detail?id=2629075614","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629075614?lang=en_us&edition=fundamental","pubTime":"2026-04-23 05:28","pubTimestamp":1776893336,"startTime":"0","endTime":"0","summary":"IceCure Medical will hold a special general meeting of shareholders May 11, 2026 via remote communication.Shareholders will vote on authorizing a potential reverse stock split of issued and outstanding ordinary shares at a ratio between 10-for-1 and 30-for-1.Board would have discretion to implement the reverse split, if approved, on a date it selects.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IceCure Medical Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 22, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nNDLK5jp6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","ICCM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629032592","title":"IceCure Medical Sees 30%+ U.S. ProSense Revenue Jump as SBI 2026 Data Underscore Cryoablation Cost Benefits","url":"https://stock-news.laohu8.com/highlight/detail?id=2629032592","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629032592?lang=en_us&edition=fundamental","pubTime":"2026-04-21 21:22","pubTimestamp":1776777731,"startTime":"0","endTime":"0","summary":"An announcement from Icecure Medical ( ($ICCM) ) is now available. On April 21, 2026, IceCure Medical reported that preliminary, unaudited U.S. rev...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/icecure-medical-sees-30-u-s-prosense-revenue-jump-as-sbi-2026-data-underscore-cryoablation-cost-benefits?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/icecure-medical-sees-30-u-s-prosense-revenue-jump-as-sbi-2026-data-underscore-cryoablation-cost-benefits?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ICCM","SBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629039043","title":"IceCure expects Q1 US ProSense revenue to rise over 30% on year","url":"https://stock-news.laohu8.com/highlight/detail?id=2629039043","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629039043?lang=en_us&edition=fundamental","pubTime":"2026-04-21 20:34","pubTimestamp":1776774844,"startTime":"0","endTime":"0","summary":"IceCure projected Q1 2026 U.S. revenue from ProSense systems and cryoprobes rose more than 30% versus Q1 2025, based on preliminary unaudited estimates.Commercial uplift followed FDA clearance in October 2025 for ProSense use in local treatment of low-risk breast cancer in women aged 70 and older.Management expects to close additional U.S. ProSense system sales in Q2 2026 as it expands installed base at academic and research hospitals.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IceCure Medical Ltd. published the original content used to generate this news brief via PR Newswire  on April 21, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260421:nNDL23RYtg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","ICCM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624414495","title":"IceCure Medical files to sell 16M ordinary share for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2624414495","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624414495?lang=en_us&edition=fundamental","pubTime":"2026-04-02 04:36","pubTimestamp":1775075801,"startTime":"0","endTime":"0","summary":"16:33 EDT IceCure Medical (ICCM) files to sell 16M ordinary share for holders Published first on TheFly – the ultimate source for real-time, market...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/icecure-medical-files-to-sell-16m-ordinary-share-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/icecure-medical-files-to-sell-16m-ordinary-share-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","ICCM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622852278","title":"IceCure prices $4.0 million registered direct offering at $0.50 per share; adds Series B and C warrants at $0.55 exercise price","url":"https://stock-news.laohu8.com/highlight/detail?id=2622852278","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622852278?lang=en_us&edition=fundamental","pubTime":"2026-03-26 20:04","pubTimestamp":1774526688,"startTime":"0","endTime":"0","summary":"IceCure prices $4.0 million registered direct offering at $0.50 per share; adds Series B and C warrants at $0.55 exercise price. IceCure entered securities purchase agreements with institutional investors to sell 8,000,000 ordinary shares in a registered direct offering at USD 0.50 per share.Gross proceeds are expected to be about USD 4.0 million, before fees and expenses.A concurrent private placement includes unregistered Series B and Series C warrants to buy up to 8,000,000 ordinary shares each, with an exercise price of USD 0.55 per share.The Series B warrants are set to expire five years after issuance, while the Series C warrants are set to expire one year after issuance.A.G.P./Alliance Global Partners is acting as sole placement agent.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nNDL824200:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ICCM","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622852110","title":"Icecure Announces Pricing of $4.0 Million Registered Direct Offering and Concurrent Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2622852110","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622852110?lang=en_us&edition=fundamental","pubTime":"2026-03-26 20:00","pubTimestamp":1774526405,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nTUA23WPWQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","ICCM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622007153","title":"IceCure Medical files Form 3 initial beneficial ownership statement; director Ron Mayron reports 296,631 ordinary shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2622007153","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622007153?lang=en_us&edition=fundamental","pubTime":"2026-03-26 05:13","pubTimestamp":1774473238,"startTime":"0","endTime":"0","summary":"IceCure director Ron Mayron filed an initial Form 3 reporting 296,631 ordinary shares beneficially owned.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IceCure Medical Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 25, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nNDL8Gxgbn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","ICCM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622007902","title":"IceCure Medical; CEO and director Eyal Shamir files initial beneficial ownership statement```","url":"https://stock-news.laohu8.com/highlight/detail?id=2622007902","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622007902?lang=en_us&edition=fundamental","pubTime":"2026-03-26 05:11","pubTimestamp":1774473114,"startTime":"0","endTime":"0","summary":"IceCure said Chief Executive Officer and director Eyal Shamir reported direct ownership of 791,381 ordinary shares in an initial statement of beneficial ownership.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IceCure Medical Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 25, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nNDL5kJ4wL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ICCM","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622107192","title":"IceCure Medical Posts Strong 5-Year Kidney Cancer Cryoablation Data From ICESECRET Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2622107192","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622107192?lang=en_us&edition=fundamental","pubTime":"2026-03-25 21:37","pubTimestamp":1774445870,"startTime":"0","endTime":"0","summary":"Icecure Medical ( ($ICCM) ) has provided an announcement. On March 25, 2026, IceCure Medical reported positive five-year top-line results from its ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/icecure-medical-posts-strong-5-year-kidney-cancer-cryoablation-data-from-icesecret-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/icecure-medical-posts-strong-5-year-kidney-cancer-cryoablation-data-from-icesecret-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","ICCM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622507507","title":"IceCure Medical reports results from clinical trial of ProSense for SRMs","url":"https://stock-news.laohu8.com/highlight/detail?id=2622507507","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622507507?lang=en_us&edition=fundamental","pubTime":"2026-03-25 20:36","pubTimestamp":1774442212,"startTime":"0","endTime":"0","summary":"IceCure Medical (ICCM) announced positive top-line results from its ICESECRET clinical trial of ProSense for the treatment of small renal masses, o...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/icecure-medical-reports-results-from-clinical-trial-of-prosense-for-srms-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/icecure-medical-reports-results-from-clinical-trial-of-prosense-for-srms-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","ICCM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622075113","title":"IceCure reports ICESECRET ProSense kidney cancer trial; recurrence-free rate rises to 89.4% for tumors ≤3 cm","url":"https://stock-news.laohu8.com/highlight/detail?id=2622075113","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622075113?lang=en_us&edition=fundamental","pubTime":"2026-03-25 20:30","pubTimestamp":1774441859,"startTime":"0","endTime":"0","summary":"IceCure Medical announced positive top-line 5-year results from its ICESECRET clinical trial of ProSense for the treatment of small renal masses in kidney cancer patients.At a median follow-up of four years, the recurrence-free rate reached 83.9% in 112 evaluated patients and rose to 89.4% in a subgroup with tumors ≤3 cm, no prior kidney cancer, and successful initial procedures.Within the evaluated group, 12 patients underwent a second cryoablation procedure at a mean of 1.73±1.2 years.More detailed data will be presented by Principal Investigator Prof. Halahmi Sarel at the European Conference on Interventional Oncology 2026 in Basel.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IceCure Medical Ltd. published the original content us","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nNDL7P6bb1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ICCM","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622075175","title":"Icecure Medical Ltd - 89.4% Recurrence-Free Rate for Tumors ≤3 Cm, 83.9% for General Population at 4 Years","url":"https://stock-news.laohu8.com/highlight/detail?id=2622075175","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622075175?lang=en_us&edition=fundamental","pubTime":"2026-03-25 20:30","pubTimestamp":1774441801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nTUA5SFXYT:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ICCM","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622075168","title":"Icecure Reports Positive 5-Year Top-Line Results From Icesecret Kidney Cancer Cryoablation Study: 89.4% and 83.9% Recurrence-Free Rates","url":"https://stock-news.laohu8.com/highlight/detail?id=2622075168","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622075168?lang=en_us&edition=fundamental","pubTime":"2026-03-25 20:30","pubTimestamp":1774441801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nTUA5SFXYT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","ICCM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621098829","title":"IceCure Medical Names New CFO and Plans Key Leadership Changes Amid ProSense® Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2621098829","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621098829?lang=en_us&edition=fundamental","pubTime":"2026-03-24 21:26","pubTimestamp":1774358770,"startTime":"0","endTime":"0","summary":"Icecure Medical ( ($ICCM) ) has shared an update. On March 19, 2026, IceCure Medical appointed veteran finance executive Meir Peleg as its new Chie...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/icecure-medical-names-new-cfo-and-plans-key-leadership-changes-amid-prosense-growth?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/icecure-medical-names-new-cfo-and-plans-key-leadership-changes-amid-prosense-growth?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ICCM","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621062934","title":"IceCure names Meir Peleg CFO effective May 17, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2621062934","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621062934?lang=en_us&edition=fundamental","pubTime":"2026-03-24 20:32","pubTimestamp":1774355520,"startTime":"0","endTime":"0","summary":"IceCure appointed Meir Peleg as chief financial officer, effective May 17, 2026.Meir Peleg has over 20 years of financial leadership experience, including roles with Nasdaq-listed companies.The company said it intends to appoint Richard Fine as medical director in Q2 2026 to lead breast indications; he is director of the Breast Program at the Margaret West Comprehensive Breast Center at West Cancer Center & Research Institute.IceCure said Naum Muchnik, vice president of R&D and engineering, will depart effective April 12, 2026, and the company has started a search for a new chief technology officer.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IceCure Medical Ltd. published the original content used to generate this news brief via PR","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nNDL3SwvV5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","ICCM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621646062","title":"BRIEF-Icecure Appoints Meir Peleg As Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2621646062","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621646062?lang=en_us&edition=fundamental","pubTime":"2026-03-24 20:31","pubTimestamp":1774355494,"startTime":"0","endTime":"0","summary":"BRIEF-Icecure Appoints Meir Peleg As Chief Financial OfficerIcecure Medical Ltd ICCM.O:ICECURE APPOINTS MEIR PELEG AS CHIEF FINANCIAL OFFICERSource text: ID:nPnb3pjcKaFurther company coverage: ICCM.O","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nTUAM6KKP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","ICCM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621062528","title":"Icecure Appoints Meir Peleg as Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2621062528","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621062528?lang=en_us&edition=fundamental","pubTime":"2026-03-24 20:30","pubTimestamp":1774355402,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nTUAM6KKP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","ICCM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621062660","title":"Press Release: IceCure Appoints Meir Peleg as Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2621062660","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621062660?lang=en_us&edition=fundamental","pubTime":"2026-03-24 20:30","pubTimestamp":1774355400,"startTime":"0","endTime":"0","summary":"Meir Peleg brings over 20 years of financial leadership and experience including with Nasdaq listed companies. IceCure intends to appoint Dr. Richard Fine as Medical Director. CAESAREA, Israel, March 24, 2026 /PRNewswire/ -- IceCure Medical Ltd.  , developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an option to surgical tumor removal, today announced the appointment of Mr. Meir Peleg as its Chief Financial Officer , effective May 17, 2026.The appointment comes as IceCure is experiencing strong commercial momentum for ProSense in the United States and globally following U.S. Food and Drug Administration  clearance in low-risk breast cancer and a recommendation by the American Society of Breast Surgeons  for the use of cryoablation in select low risk breast cancer patients.\"We are pleased to welcome Meir to IceCure as we build strong commercial momentum in the U.S. and globally,\" stated IceCure's Chief Executive Officer Eyal Shamir. \"We believe hi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"8603dabb40994e59ac78c04c930c0d49","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4232","ICCM","BK4022","BK4082","R"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620198402","title":"Icecure Medical Rides FDA, ASBRS Wins to Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2620198402","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620198402?lang=en_us&edition=fundamental","pubTime":"2026-03-18 08:16","pubTimestamp":1773792996,"startTime":"0","endTime":"0","summary":"Icecure Medical Ltd. (($ICCM)) has held its Q4 earnings call. Read on for the main highlights of the call. Icecure Medical’s latest earnings call s...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/icecure-medical-rides-fda-asbrs-wins-to-growth?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/icecure-medical-rides-fda-asbrs-wins-to-growth?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","ICCM","BK4082","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.icecure-medical.com","stockEarnings":[{"period":"1week","weight":0.0757},{"period":"1month","weight":0.001},{"period":"3month","weight":-0.507},{"period":"6month","weight":-0.5771},{"period":"1year","weight":-0.7403},{"period":"ytd","weight":-0.5061}],"compareEarnings":[{"period":"1week","weight":0.0094},{"period":"1month","weight":0.0998},{"period":"3month","weight":0.0414},{"period":"6month","weight":0.0566},{"period":"1year","weight":0.2904},{"period":"ytd","weight":0.0568}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors. The company offers ProSense system, a single probe system for the treatment of tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MultiSense, a multi probe system for the treatment of multiple and larger tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.006729},{"month":2,"riseRate":0.4,"avgChangeRate":-0.024554},{"month":3,"riseRate":0.4,"avgChangeRate":-0.136228},{"month":4,"riseRate":0.4,"avgChangeRate":0.00193},{"month":5,"riseRate":0.2,"avgChangeRate":-0.102087},{"month":6,"riseRate":0.25,"avgChangeRate":-0.086655},{"month":7,"riseRate":0.75,"avgChangeRate":0.017122},{"month":8,"riseRate":0.25,"avgChangeRate":-0.047246},{"month":9,"riseRate":0,"avgChangeRate":-0.204904},{"month":10,"riseRate":0.4,"avgChangeRate":0.0455},{"month":11,"riseRate":0.6,"avgChangeRate":-0.016804},{"month":12,"riseRate":0.4,"avgChangeRate":0.06553}],"exchange":"NASDAQ","name":"IceCure Medical Ltd.","nameEN":"IceCure Medical Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"IceCure Medical Ltd.(ICCM),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest IceCure Medical Ltd.(ICCM) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"IceCure Medical Ltd.,ICCM,IceCure Medical Ltd.股票,IceCure Medical Ltd.股票老虎,IceCure Medical Ltd.股票老虎国际,IceCure Medical Ltd.行情,IceCure Medical Ltd.股票行情,IceCure Medical Ltd.股价,IceCure Medical Ltd.股市,IceCure Medical Ltd.股票价格,IceCure Medical Ltd.股票交易,IceCure Medical Ltd.股票购买,IceCure Medical Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"IceCure Medical Ltd.(ICCM),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest IceCure Medical Ltd.(ICCM) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}